Benefits of Combined Phage–Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review
Abstract
Share and Cite
Diallo, K.; Dublanchet, A. Benefits of Combined Phage–Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review. Antibiotics 2022, 11, 839. https://doi.org/10.3390/antibiotics11070839
Diallo K, Dublanchet A. Benefits of Combined Phage–Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review. Antibiotics. 2022; 11(7):839. https://doi.org/10.3390/antibiotics11070839
Chicago/Turabian StyleDiallo, Kevin, and Alain Dublanchet. 2022. "Benefits of Combined Phage–Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review" Antibiotics 11, no. 7: 839. https://doi.org/10.3390/antibiotics11070839
APA StyleDiallo, K., & Dublanchet, A. (2022). Benefits of Combined Phage–Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review. Antibiotics, 11(7), 839. https://doi.org/10.3390/antibiotics11070839

